Kidney Disease Management
253 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which part of the nephron is responsible for reabsorbing sodium, chloride, calcium, and water back into the bloodstream and regulating blood pH?

  • Glomerulus
  • Bowman's capsule
  • Proximal tubule (correct)
  • Loop of Henle

    • What is the major site of action for thiazide diuretics within the nephron?

  • Loop of Henle
  • Glomerulus
  • Collecting duct
  • Distal convoluted tubule (correct)

    • Which part of the nephron plays a crucial role in reabsorbing water and regulating sodium and chloride concentrations?

  • Distal convoluted tubule
  • Bowman's capsule
  • Proximal tubule
  • Loop of Henle (correct)

    • What is the major filtering unit within the nephron that allows substances with a molecular weight < 40,000 daltons to pass through into the filtrate?

    <p>Glomerulus</p> Signup and view all the answers

    Which part of the nephron is responsible for regulating potassium, sodium, calcium, and pH?

    <p>Distal convoluted tubule</p> Signup and view all the answers

    What is the major method for assessing the severity of kidney disease?

    <p>Glomerular filtration rate (GFR)</p> Signup and view all the answers

    Which type of phosphate binder is considered first-line treatment?

    <p>Calcium-based binders</p> Signup and view all the answers

    What is a specific risk associated with aluminum-based binders?

    <p>Aluminum accumulation</p> Signup and view all the answers

    What is a potential side effect of calcium-based binders?

    <p>Hypercalcemia</p> Signup and view all the answers

    Which type of phosphate binder is less likely to cause hypercalcemia but is more expensive?

    <p>Aluminum-free, calcium-free binders</p> Signup and view all the answers

    What are the specific considerations for lanthanum carbonate and sevelamer?

    <p>Non-calcium, non-aluminum binders</p> Signup and view all the answers

    What is a specific interaction consideration for lanthanum carbonate?

    <p>Antacids containing aluminum, calcium, or magnesium</p> Signup and view all the answers

    Which of the following is a common cause of chronic kidney disease (CKD)?

    <p>Diabetes and hypertension</p> Signup and view all the answers

    What is the most common cause of acute kidney injury (AKI)?

    <p>Dehydration</p> Signup and view all the answers

    How is the degree of kidney function measured in chronic kidney disease (CKD)?

    <p>Glomerular filtration rate (GFR) or creatinine clearance (CrCl)</p> Signup and view all the answers

    What is the definition of end-stage renal disease (ESRD)?

    <p>Total and permanent kidney failure</p> Signup and view all the answers

    What is the common presentation of dehydration-induced acute kidney injury (AKI)?

    <p>BUN:SCr ratio &gt; 20:1 plus decreased urine output, dry mucus membranes, tachycardia</p> Signup and view all the answers

    How can chronic kidney disease (CKD) be prevented from progressing to end-stage renal disease (ESRD)?

    <p>Controlling blood glucose and blood pressure</p> Signup and view all the answers

    What is the recommended action if serum creatinine (SCr) increases by >30% in a patient on medication management for kidney disease?

    <p>Discontinue treatment and refer to a nephrologist</p> Signup and view all the answers

    What is the advised action regarding the use of ACE inhibitors and ARBs together in patients with kidney disease?

    <p>They should not be used together due to the risk of hyperkalemia</p> Signup and view all the answers

    When should serum creatinine and potassium be monitored after initiating ACE inhibitors or ARBs in patients with kidney disease?

    <p>1-2 weeks after initiation</p> Signup and view all the answers

    What should patients on ACE inhibitors or ARBs avoid while on these medications?

    <p>Potassium supplements and salt substitutes (with KCl)</p> Signup and view all the answers

    What is the recommended approach to dose of ACE inhibitors or ARBs for renal protection in patients with kidney disease?

    <p>Maximize the dose</p> Signup and view all the answers

    What is the first-line treatment for patients with chronic kidney disease (CKD), type 2 diabetes, and an estimated glomerular filtration rate (eGFR) of 30 mL/min/1.73 m2?

    <p>Metformin and SGLT2 inhibitors</p> Signup and view all the answers

    Which equation is used to calculate creatinine clearance (CrCl)?

    <p>Cockcroft-Gault: $((140 - ext{age}) imes ext{weight}) / (72 imes ext{SCr})$</p> Signup and view all the answers

    What is the normal range for serum creatinine (SCr)?

    <p>0.6-1.3 mg/dL</p> Signup and view all the answers

    Which equation is used to estimate glomerular filtration rate (GFR)?

    <p>MDRD: $186 imes ( ext{SCr})^{-1.154} imes ( ext{age})^{-0.203} \times 0.742$ (if female) $\times 1.210$ (if Black)</p> Signup and view all the answers

    What is a key indicator of kidney disease severity in the context of estimated GFR (eGFR) calculation?

    <p>Albuminuria</p> Signup and view all the answers

    Which blood pressure target is recommended for patients with hypertension and CKD?

    <p>Systolic blood pressure (SBP) &lt; 120 mmHg</p> Signup and view all the answers

    What is the first-line medication for patients with CKD, hypertension, and albuminuria?

    <p>ACE inhibitor or ARB</p> Signup and view all the answers

    What is the estimated number of U.S. adults with chronic kidney disease (CKD)?

    <p>False</p> Signup and view all the answers

    Chronic Kidney Disease (CKD) is commonly caused by diabetes and hypertension.

    <p>True</p> Signup and view all the answers

    The glomerular filtration rate (GFR) measures the degree of kidney function in CKD.

    <p>True</p> Signup and view all the answers

    End-Stage Renal Disease (ESRD) can be reversible with timely intervention.

    <p>False</p> Signup and view all the answers

    Polycystic kidney disease is a common cause of CKD

    <p>False</p> Signup and view all the answers

    Pharmacists do not play a crucial role in assessing kidney impairment in CKD patients

    <p>False</p> Signup and view all the answers

    The nephron is responsible for regulating blood sugar levels

    <p>False</p> Signup and view all the answers

    The loop of Henle plays a crucial role in reabsorbing water and regulating sodium and chloride concentrations

    <p>True</p> Signup and view all the answers

    The distal convoluted tubule is the site of action for loop diuretics

    <p>False</p> Signup and view all the answers

    The collecting duct is responsible for water and electrolyte balance

    <p>True</p> Signup and view all the answers

    Drug-induced kidney disease (DIKD) is only linked to a few medications

    <p>False</p> Signup and view all the answers

    Risk factors for DIKD include decreased renal blood flow

    <p>True</p> Signup and view all the answers

    The glomerular filtration rate (GFR) is not used to assess kidney disease severity

    <p>False</p> Signup and view all the answers

    The proximal tubule reabsorbs potassium back into the bloodstream

    <p>False</p> Signup and view all the answers

    Renal artery stenosis is a common cause of CKD

    <p>False</p> Signup and view all the answers

    The major parts of the nephron include Bowman's capsule, glomerulus, proximal tubule, loop of Henle, and distal convoluted tubule

    <p>False</p> Signup and view all the answers

    Loop diuretics are not considered to be common medications that can cause renal disease.

    <p>False</p> Signup and view all the answers

    The Cockcroft-Gault equation for CrCl takes into account patient age, serum creatinine (SCr), and weight.

    <p>True</p> Signup and view all the answers

    Blood urea nitrogen (BUN) measures urea levels and SCr indicates liver function.

    <p>False</p> Signup and view all the answers

    The Cockcroft-Gault equation for CrCl is not affected by low muscle mass, obesity, liver disease, pregnancy, or high muscle mass.

    <p>False</p> Signup and view all the answers

    Pharmacists typically base medication dosing recommendations on GFR.

    <p>False</p> Signup and view all the answers

    CKD-EPI and MDRD equations are used for staging kidney disease and dosing select drugs like metformin and SGLT2 inhibitors.

    <p>True</p> Signup and view all the answers

    GFR and degree of albuminuria are used to assess the severity of kidney disease, with a GFR < 60 mL/min/1.73 m2 and/or albuminuria indicating chronic kidney disease (CKD).

    <p>True</p> Signup and view all the answers

    A target systolic blood pressure (SBP) < 120 mmHg is recommended for patients with hypertension and CKD.

    <p>True</p> Signup and view all the answers

    An ACE inhibitor or ARB is not first-line for patients with CKD, hypertension, and albuminuria.

    <p>False</p> Signup and view all the answers

    When starting treatment with an ACE inhibitor or ARB, the baseline SCr can increase by up to 10%, which is expected and should not prompt treatment cessation.

    <p>False</p> Signup and view all the answers

    The 2021 KDIGO Guideline on Blood Pressure in CKD recommends a higher target SBP for those with hypertension and CKD, compared to the general population.

    <p>False</p> Signup and view all the answers

    Discontinuation of treatment and referral to a nephrologist is recommended if SCr increases by >30%

    <p>True</p> Signup and view all the answers

    ACE inhibitors and ARBs should not be used together due to the risk of hyperkalemia

    <p>True</p> Signup and view all the answers

    Monitoring of serum creatinine and potassium is advised 1-2 weeks after initiating ACE inhibitors or ARBs

    <p>True</p> Signup and view all the answers

    Patients should avoid potassium supplements and salt substitutes (with KCl) while on ACE inhibitors or ARBs

    <p>True</p> Signup and view all the answers

    Maximize the dose of ACE inhibitors or ARBs for renal protection

    <p>False</p> Signup and view all the answers

    Recommended in all patients with albuminuria to prevent kidney disease progression

    <p>False</p> Signup and view all the answers

    First-line treatment for patients with CKD, type 2 diabetes, and eGFR 30 mL/min/1.73 m2 is metformin and SGLT2 inhibitors

    <p>False</p> Signup and view all the answers

    SGLT2 inhibitors have shown reduction in cardiovascular events and CKD progression

    <p>True</p> Signup and view all the answers

    Dose adjustments may be necessary when CrCl is < 60 mL/min; additional adjustments or contraindication may be needed when CrCI is < 30 mL/min

    <p>True</p> Signup and view all the answers

    CKD mineral and bone disorder (CKD-MBD) is common in patients with renal impairment and affects almost all patients receiving dialysis

    <p>True</p> Signup and view all the answers

    CKD-MBD is associated with fractures, cardiovascular disease, and increased mortality

    <p>True</p> Signup and view all the answers

    Hyperphosphatemia contributes to chronically elevated PTH levels and must be treated to prevent bone disease and fractures

    <p>True</p> Signup and view all the answers

    Phosphate binders block P04 absorption in the stomach and should be taken with meals

    <p>False</p> Signup and view all the answers

    Aluminum-based binders are commonly used due to their potent effect in CKD treatment

    <p>False</p> Signup and view all the answers

    Lanthanum carbonate and sevelamer are both calcium-based phosphate binders

    <p>False</p> Signup and view all the answers

    Sucroferric oxyhydroxide and ferric citrate are iron-based phosphate binders

    <p>True</p> Signup and view all the answers

    Phosphate binders have minimal drug interactions and can be safely administered alongside other medications

    <p>False</p> Signup and view all the answers

    Lanthanum carbonate has interactions with aluminum-, calcium-, or magnesium-containing antacids and quinolone antibiotics

    <p>True</p> Signup and view all the answers

    Careful administration timing is not crucial for avoiding interactions with levothyroxine and antibiotic medications

    <p>False</p> Signup and view all the answers

    Calcium-based binders are less likely to cause hypercalcemia but are more expensive

    <p>False</p> Signup and view all the answers

    Aluminum-based binders are rarely used due to the risk of aluminum accumulation

    <p>True</p> Signup and view all the answers

    Chronic Kidney Disease (CKD) disrupts Ca, P04, and vitamin D balance, leading to increased PTH, bone demineralization, and anemia

    <p>True</p> Signup and view all the answers

    Phosphate binders are not essential in the treatment of CKD

    <p>False</p> Signup and view all the answers

    Lanthanum carbonate and sevelamer are non-calcium, non-aluminum binders with specific considerations and side effects

    <p>True</p> Signup and view all the answers

    Explain the difference between acute kidney injury (AKI) and chronic kidney disease (CKD) and provide an example of a common cause for each.

    <p>Acute kidney injury (AKI) is a sudden loss of kidney function due to a non-renal condition, often reversible if the precipitating condition is corrected. A common cause is dehydration. Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years, often caused by conditions like diabetes and hypertension.</p> Signup and view all the answers

    Define end-stage renal disease (ESRD) and explain the medical intervention needed for patients with ESRD.

    <p>End-stage renal disease (ESRD) is total and permanent kidney failure, requiring dialysis or transplant to perform the functions of the kidneys.</p> Signup and view all the answers

    Discuss the risk factors for chronic kidney disease (CKD) and the preventive measures for renal damage and progression to ESRD.

    <p>The risk factors for CKD include diabetes and hypertension. Controlling blood glucose and blood pressure can prevent renal damage and delay progression to end-stage renal disease (ESRD).</p> Signup and view all the answers

    Explain the importance of glomerular filtration rate (GFR) and creatinine clearance (CrCl) in assessing kidney function, and describe the measurement of kidney function using these parameters.

    <p>Glomerular filtration rate (GFR) and creatinine clearance (CrCl) are important indicators of kidney function. GFR is often measured using the CKD-EPI or MDRD equations, while CrCl is calculated using the Cockcroft-Gault equation.</p> Signup and view all the answers

    Explain the monitoring recommendations for serum creatinine and potassium after initiating ACE inhibitors or ARBs in patients with kidney disease.

    <p>Monitoring of serum creatinine and potassium is advised 1-2 weeks after initiating ACE inhibitors or ARBs.</p> Signup and view all the answers

    What is the first-line treatment for patients with CKD, type 2 diabetes, and an eGFR of 30 mL/min/1.73 m$^2$?

    <p>Metformin and SGLT2 inhibitors</p> Signup and view all the answers

    What is the recommended action if serum creatinine (SCr) increases by more than 30% in a patient on medication management for kidney disease?

    <p>Discontinuation of treatment and referral to a nephrologist</p> Signup and view all the answers

    Why should ACE inhibitors and ARBs not be used together in patients with kidney disease?

    <p>Due to the risk of hyperkalemia</p> Signup and view all the answers

    What is the common complication associated with CKD-MBD?

    <p>Fractures, cardiovascular disease, and increased mortality</p> Signup and view all the answers

    What is the target systolic blood pressure recommended for patients with hypertension and CKD?

    <p>Systolic blood pressure less than 120 mmHg</p> Signup and view all the answers

    What is the impact of hyperphosphatemia on PTH levels and bone health in patients with kidney disease?

    <p>Hyperphosphatemia contributes to chronically elevated PTH levels and must be treated to prevent bone disease and fractures</p> Signup and view all the answers

    What is the role of SGLT2 inhibitors in patients with CKD?

    <p>SGLT2 inhibitors have shown reduction in cardiovascular events and CKD progression</p> Signup and view all the answers

    How should dose adjustments be made for medications when CrCl is less than 60 mL/min? What about when CrCl is less than 30 mL/min?

    <p>Dose adjustments may be necessary when CrCl is less than 60 mL/min; additional adjustments or contraindication may be needed when CrCl is less than 30 mL/min</p> Signup and view all the answers

    What is the recommended approach to the dose of ACE inhibitors or ARBs for renal protection in patients with kidney disease?

    <p>Maximize the dose of ACE inhibitors or ARBs for renal protection</p> Signup and view all the answers

    What is the impact of CKD-MBD on patients receiving dialysis?

    <p>CKD-MBD is common in patients with renal impairment and affects almost all patients receiving dialysis</p> Signup and view all the answers

    What should patients on ACE inhibitors or ARBs avoid while on these medications?

    <p>Patients should avoid potassium supplements and salt substitutes (with KCl) while on ACE inhibitors or ARBs</p> Signup and view all the answers

    Explain the significance of the Cockcroft-Gault equation in medication dosing for kidney disease management.

    <p>The Cockcroft-Gault equation is used to calculate creatinine clearance (CrCl), which helps determine the appropriate dosage of medications for patients with kidney disease.</p> Signup and view all the answers

    What are the normal ranges for serum creatinine (SCr) and how is it used to estimate kidney function?

    <p>The normal range for SCr is 0.6-1.3 mg/dL. SCr is used, along with blood urea nitrogen (BUN), to estimate kidney function.</p> Signup and view all the answers

    How is estimated glomerular filtration rate (eGFR) calculated and what role does it play in kidney disease management?

    <p>eGFR is calculated using the MDRD and CKD-EPI equations. It is used to assess the severity of kidney disease and to dose select drugs like metformin and SGLT2 inhibitors.</p> Signup and view all the answers

    What is the recommended target systolic blood pressure (SBP) for patients with hypertension and CKD, and why is it important?

    <p>The recommended target SBP is &lt; 120 mmHg for patients with hypertension and CKD. Lowering blood pressure helps to slow the progression of kidney disease.</p> Signup and view all the answers

    Explain the first-line treatment for patients with CKD, hypertension, and albuminuria, and the rationale behind it.

    <p>An ACE inhibitor or ARB is the first-line treatment for these patients. RAAS inhibition with these medications reduces CKD progression.</p> Signup and view all the answers

    What factors can affect the accuracy of the Cockcroft-Gault equation for CrCl, and how do they impact medication dosing?

    <p>Low muscle mass, obesity, liver disease, pregnancy, or high muscle mass can affect the accuracy of the Cockcroft-Gault equation. This can lead to improper medication dosing.</p> Signup and view all the answers

    How is blood urea nitrogen (BUN) used to estimate kidney function, and what does it measure?

    <p>BUN is used, along with SCr, to estimate kidney function. It measures urea levels in the blood.</p> Signup and view all the answers

    What role does creatinine clearance (CrCl) play in medication dosing for kidney disease, and how is it calculated?

    <p>CrCl is used for medication dosing, and it is calculated using the Cockcroft-Gault equation, which takes into account patient age, SCr, and weight.</p> Signup and view all the answers

    What equations are used for staging kidney disease and dosing select drugs, and what other indicator is used to assess kidney disease severity?

    <p>The CKD-EPI and MDRD equations are used for staging kidney disease and dosing select drugs. Albuminuria is also used as a key indicator of kidney disease severity.</p> Signup and view all the answers

    What is the significance of estimating GFR (eGFR) in the management of kidney disease, and how is it calculated?

    <p>eGFR is used to assess the severity of kidney disease and is calculated using the MDRD and CKD-EPI equations. It helps guide treatment decisions.</p> Signup and view all the answers

    How do hypertension and RAAS inhibition contribute to the management of kidney disease, and what is the recommended target SBP for patients with hypertension and CKD?

    <p>Hypertension worsens CKD, and RAAS inhibition with medications like ACE inhibitors and ARBs reduces CKD progression. The recommended target SBP for these patients is &lt; 120 mmHg.</p> Signup and view all the answers

    What specific drugs use glomerular filtration rate (GFR) for dosing adjustments, and what role does GFR play in medication dosing?

    <p>SGLT2 inhibitors and metformin use GFR for dosing adjustments. GFR is used to determine appropriate dosages for medications in patients with kidney disease.</p> Signup and view all the answers

    Explain the role of the nephron in kidney function and regulation of blood volume and pressure.

    <p>The nephron is the functional unit of the kidney responsible for controlling sodium and water concentration, regulating blood volume and pressure.</p> Signup and view all the answers

    List the major parts of the nephron and their functions.

    <p>The major parts of the nephron include Bowman's capsule (filtration), glomerulus (filtration), proximal tubule (reabsorption of sodium, chloride, calcium, and water), loop of Henle (reabsorption of water and regulation of sodium and chloride concentrations), distal convoluted tubule (regulation of potassium, sodium, calcium, and pH), and collecting duct (water and electrolyte balance).</p> Signup and view all the answers

    What is the glomerular filtration rate (GFR) and how is it used to assess kidney disease severity?

    <p>The glomerular filtration rate (GFR) measures the flow rate of filtered fluid through the kidney. It is used to assess kidney disease severity, with a GFR &lt; 60 $mL/min/1.73 m^2$ indicating chronic kidney disease (CKD).</p> Signup and view all the answers

    Explain the reabsorption functions of the proximal tubule and the loop of Henle within the nephron.

    <p>The proximal tubule reabsorbs sodium, chloride, calcium, and water back into the bloodstream and regulates blood pH. The loop of Henle plays a crucial role in reabsorbing water and regulating sodium and chloride concentrations.</p> Signup and view all the answers

    Describe the involvement of the distal convoluted tubule in kidney function and its relevance to medication action.

    <p>The distal convoluted tubule is involved in regulating potassium, sodium, calcium, and pH. It is the site of action for thiazide diuretics.</p> Signup and view all the answers

    What is the role of the collecting duct in kidney function and its susceptibility to medication action?

    <p>The collecting duct is responsible for water and electrolyte balance, affected by levels of ADH and aldosterone. It is the site of action for potassium-sparing diuretics.</p> Signup and view all the answers

    Explain the significance of drug-induced kidney disease (DIKD) and its association with medications.

    <p>Drug-induced kidney disease (DIKD) is linked to numerous medications, can be acute or irreversible, and is especially common in the hospital setting.</p> Signup and view all the answers

    List the risk factors associated with drug-induced kidney disease (DIKD).

    <p>Risk factors for DIKD include reduced renal blood flow, increased age, use of multiple nephrotoxic medications, and frequent use or large doses of nephrotoxic medications.</p> Signup and view all the answers

    What is the major filtering unit within the nephron and what substances can pass through it into the filtrate?

    <p>The glomerulus, located within Bowman's capsule, is a large filtering unit that allows substances with a molecular weight &lt; 40,000 daltons to pass through into the filtrate and be excreted in the urine.</p> Signup and view all the answers

    How is kidney disease severity assessed, and what are the key indicators used in assessment?

    <p>The severity of kidney disease is assessed using the glomerular filtration rate (GFR) and the amount of albumin in the urine.</p> Signup and view all the answers

    Explain the role of pharmacists in assessing kidney impairment and ensuring safe medication dosing for CKD patients.

    <p>Pharmacists play a crucial role in assessing kidney impairment in CKD patients to ensure safe and effective medication dosing.</p> Signup and view all the answers

    What are some less common causes of chronic kidney disease (CKD) aside from diabetes and hypertension?

    <p>Less common causes of CKD include polycystic kidney disease, certain infections, renal artery stenosis, and drug-induced kidney disease.</p> Signup and view all the answers

    What are the three types of phosphate binders used in chronic kidney disease?

    <p>aluminum-based, calcium-based, and aluminum-free, calcium-free drugs</p> Signup and view all the answers

    What are the potential consequences of CKD on calcium, phosphate, and vitamin D balance?

    <p>increased PTH, bone demineralization, and anemia</p> Signup and view all the answers

    Why are aluminum-based phosphate binders rarely used in CKD treatment?

    <p>due to the risk of aluminum accumulation</p> Signup and view all the answers

    What are the potential side effects of calcium-based phosphate binders?

    <p>hypercalcemia and constipation</p> Signup and view all the answers

    What are the characteristics of aluminum-free, calcium-free phosphate binders?

    <p>less likely to cause hypercalcemia but are more expensive</p> Signup and view all the answers

    Name two non-calcium, non-aluminum phosphate binders and their specific considerations and side effects.

    <p>lanthanum carbonate and sevelamer; specific considerations and side effects</p> Signup and view all the answers

    Why is careful administration timing crucial for phosphate binders?

    <p>to avoid interactions with other medications</p> Signup and view all the answers

    What are two iron-based phosphate binders and their specific interaction considerations?

    <p>sucroferric oxyhydroxide and ferric citrate; specific interaction considerations</p> Signup and view all the answers

    What are the specific interactions of lanthanum carbonate with other medications?

    <p>aluminum-, calcium-, or magnesium-containing antacids and quinolone antibiotics</p> Signup and view all the answers

    What is crucial for avoiding interactions with levothyroxine and antibiotic medications when administering phosphate binders?

    <p>careful administration timing</p> Signup and view all the answers

    Why is aluminum accumulation a concern with aluminum-based phosphate binders?

    <p>due to the risk of aluminum toxicity over time</p> Signup and view all the answers

    What are the potential consequences of hypercalcemia caused by calcium-based phosphate binders?

    <p>hypercalcemia can lead to various complications such as kidney stones and impaired kidney function</p> Signup and view all the answers

    Which vitamin D analog is known to cause less hypercalcemia than calcitriol?

    <p>Paricalcitol</p> Signup and view all the answers

    What is the primary dietary source of vitamin D2?

    <p>Ergocalciferol</p> Signup and view all the answers

    Which medication mimics the actions of calcium on the parathyroid gland to reduce PTH levels?

    <p>Cinacalcet</p> Signup and view all the answers

    What occurs when the kidney is unable to hydroxylate vitamin D to its final active form?

    <p>Elevated PTH levels</p> Signup and view all the answers

    Which factor primarily determines drug removal during dialysis?

    <p>Molecular weight/size</p> Signup and view all the answers

    What is the primary function of the peritoneal membrane in peritoneal dialysis (PD)?

    <p>Act as the semipermeable membrane</p> Signup and view all the answers

    What is the main difference between home hemodialysis (HD) and peritoneal dialysis (PD)?

    <p>Frequency of treatment</p> Signup and view all the answers

    In peritoneal dialysis (PD), how is the dialysis solution processed within the body?

    <p>Pumped into the peritoneal cavity and then drained</p> Signup and view all the answers

    Which of the following factors affects drug removal during dialysis by the HD filters?

    <p>Blood flow rate</p> Signup and view all the answers

    What is the main function of the peritoneal membrane in peritoneal dialysis (PD)?

    <p>Act as the semipermeable membrane</p> Signup and view all the answers

    What is the primary function of the peritoneal membrane in peritoneal dialysis (PD)?

    <p>Act as the semipermeable membrane</p> Signup and view all the answers

    Which factor primarily determines drug removal during dialysis?

    <p>Molecular weight/size</p> Signup and view all the answers

    Which medication stabilizes myocardial cells to prevent arrhythmias but does not decrease potassium levels?

    <p>Calcium gluconate</p> Signup and view all the answers

    What is the urgent clinical need in severe hyperkalemia?

    <p>To stabilize myocardial cells</p> Signup and view all the answers

    Which medication is used to shift potassium intracellularly?

    <p>Albuterol</p> Signup and view all the answers

    What are the two primary types of dialysis in stage 5 renal disease?

    <p>Hemodialysis and peritoneal dialysis</p> Signup and view all the answers

    Which medication binds potassium in the GI tract with varying onset times and routes of administration?

    <p>Sodium zirconium cyclosilicate</p> Signup and view all the answers

    What is the treatment for metabolic acidosis in renal disease?

    <p>Sodium bicarbonate</p> Signup and view all the answers

    Which medication is used to stimulate potassium elimination?

    <p>Furosemide</p> Signup and view all the answers

    Which medication is used to bind potassium in the GI tract?

    <p>Sodium polystyrene sulfonate</p> Signup and view all the answers

    What is the purpose of using ACE inhibitors and aldosterone receptor antagonists in the context of hyperkalemia?

    <p>To raise potassium levels</p> Signup and view all the answers

    What is the role of heparin in the context of hyperkalemia?

    <p>To raise potassium levels</p> Signup and view all the answers

    What is the role of NSAIDs in the context of hyperkalemia?

    <p>To raise potassium levels</p> Signup and view all the answers

    What is the role of potassium-containing IV fluids in the context of hyperkalemia?

    <p>To raise potassium levels</p> Signup and view all the answers

    Which of the following is a calcimimetic agent used in the treatment of secondary hyperparathyroidism in CKD?

    <p>Etelcalcetide</p> Signup and view all the answers

    What is the recommended hemoglobin level at which erythropoiesis-stimulating agents (ESAs) should be used cautiously and discontinued if it exceeds?

    <p>Less than 10 g/dL</p> Signup and view all the answers

    What is crucial for the effectiveness of erythropoiesis-stimulating agents (ESAs) in the management of anemia in CKD?

    <p>Adequate iron availability</p> Signup and view all the answers

    What is the primary cause of hyperkalemia in CKD?

    <p>Decreased renal excretion of potassium</p> Signup and view all the answers

    Which of the following symptoms can indicate hyperkalemia?

    <p>Muscle weakness and bradycardia</p> Signup and view all the answers

    What is the normal potassium level in the blood?

    <p>3 - 5 mEq/L</p> Signup and view all the answers

    What influences renal potassium excretion in the body?

    <p>Aldosterone and diuretics</p> Signup and view all the answers

    What is the primary cause of anemia in CKD?

    <p>Reduced erythropoietin (EPO) production</p> Signup and view all the answers

    What is the role of intravenous iron supplementation in end-stage renal disease (ESRD) patients?

    <p>To offset reduced GI absorption and blood loss from dialysis</p> Signup and view all the answers

    What is the most prevalent cause of hyperkalemia in hospitalized patients and those with diabetes?

    <p>Decreased renal excretion of potassium</p> Signup and view all the answers

    What is the function of insulin in regulating potassium levels in the body?

    <p>Shifting potassium into cells</p> Signup and view all the answers

    Which of the following is a phosphate binder used in the treatment of CKD-MBD?

    <p>Sevelamer</p> Signup and view all the answers

    Vitamin D2 is synthesized in the skin after exposure to ultraviolet light

    <p>False</p> Signup and view all the answers

    Supplementation with oral ergocalciferol or cholecalciferol is necessary in patients with early CKD (e.g., stage 3 and 4)

    <p>True</p> Signup and view all the answers

    Calcitriol (Rocaltrol) is the active form of vitamin D2

    <p>False</p> Signup and view all the answers

    Cinacalcet (Sensipar) is a 'calcimimetic' which mimics the actions of calcium on the parathyroid gland and causes a further reduction in PTH

    <p>True</p> Signup and view all the answers

    What is the primary function of the peritoneal membrane in peritoneal dialysis (PD)?

    <p>False</p> Signup and view all the answers

    Patients who do HD at home can do it more frequently (e.g., 5- 6 times per week).

    <p>True</p> Signup and view all the answers

    In PD, a dialysis solution is left in the abdomen to 'dwell' for a period of time, then is drained. This cycle is repeated throughout the day, every day.

    <p>True</p> Signup and view all the answers

    Patients who do HD at home typically perform it several times per week, usually three times.

    <p>False</p> Signup and view all the answers

    In peritoneal dialysis (PD), the peritoneal membrane acts as the semipermeable membrane (i.e., as the dialyzer).

    <p>True</p> Signup and view all the answers

    In hemodialysis (HD), high-flux filters remove more substances than conventional/low-flux filters.

    <p>True</p> Signup and view all the answers

    The loop of Henle plays a crucial role in reabsorbing water and regulating sodium and chloride concentrations.

    <p>True</p> Signup and view all the answers

    HD is a 3 - 4 hour process, several times per week (usually three times).

    <p>True</p> Signup and view all the answers

    Drugs that raise potassium levels include ACE inhibitors, heparin, aldosterone receptor antagonists, NSAIDs, and potassium-containing IV fluids.

    <p>True</p> Signup and view all the answers

    In severe hyperkalemia, the urgent clinical need is to stabilize myocardial cells and rapidly shift potassium intracellularly or induce elimination from the body.

    <p>True</p> Signup and view all the answers

    Calcium gluconate stabilizes myocardial cells to prevent arrhythmias but does not decrease potassium levels.

    <p>True</p> Signup and view all the answers

    Dialysis becomes necessary in stage 5 renal disease, with the two primary types being hemodialysis (HD) and peritoneal dialysis (PD).

    <p>True</p> Signup and view all the answers

    Sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate bind potassium in the GI tract, with varying onset times and routes of administration.

    <p>True</p> Signup and view all the answers

    Metabolic acidosis in renal disease can be treated with sodium bicarbonate or sodium citrate/citric acid solutions, with associated monitoring and precautions.

    <p>True</p> Signup and view all the answers

    Albuterol and furosemide stimulate potassium elimination.

    <p>True</p> Signup and view all the answers

    Insulin, dextrose, and sodium bicarbonate are used to shift potassium intracellularly.

    <p>True</p> Signup and view all the answers

    Medication options for hyperkalemia management include calcium gluconate, regular insulin, dextrose, sodium bicarbonate, albuterol, furosemide, sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate.

    <p>True</p> Signup and view all the answers

    ACE inhibitors and ARBs should not be used together due to the risk of hyperkalemia

    <p>True</p> Signup and view all the answers

    Drugs used for managing hyperkalemia and metabolic acidosis in renal disease have specific mechanisms, dosing, and monitoring requirements, and should be used with caution in the context of patient comorbidities and other medications.

    <p>True</p> Signup and view all the answers

    What occurs when the kidney is unable to hydroxylate vitamin D to its final active form?

    <p>False</p> Signup and view all the answers

    Vitamin D analogs such as calcitriol, calcifediol, and paricalcitol can be used to treat secondary hyperparathyroidism in CKD.

    <p>True</p> Signup and view all the answers

    Erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa are the first-line treatment for anemia of chronic kidney disease (CKD).

    <p>False</p> Signup and view all the answers

    ESAs should be used cautiously when hemoglobin is less than 10 g/dL and discontinued if it exceeds 12 g/dL due to increased risk of thromboembolic disease.

    <p>False</p> Signup and view all the answers

    Intravenous iron supplementation is often necessary in CKD patients, particularly in end-stage renal disease (ESRD) due to reduced GI absorption and blood loss from dialysis.

    <p>True</p> Signup and view all the answers

    Hyperkalemia is defined as a potassium level > 4 mEq/L.

    <p>False</p> Signup and view all the answers

    Symptoms of hyperkalemia can include muscle weakness, tachycardia, and fatal arrhythmias.

    <p>False</p> Signup and view all the answers

    Dietary restriction of potassium is the primary treatment for hyperkalemia.

    <p>False</p> Signup and view all the answers

    The normal potassium level is 3.5 - 5.5 mEq/L.

    <p>False</p> Signup and view all the answers

    Renal potassium excretion is influenced by factors such as aldosterone, antidiuretic hormone, and urine flow.

    <p>False</p> Signup and view all the answers

    Anemia in CKD is primarily due to increased erythropoietin (EPO) production by the kidneys.

    <p>False</p> Signup and view all the answers

    Anemia management involves ESAs to stimulate RBC production, which requires adequate iron availability.

    <p>True</p> Signup and view all the answers

    The Cockcroft-Gault equation for CrCl is not affected by patient age, serum creatinine (SCr), and weight.

    <p>False</p> Signup and view all the answers

    Explain the role of vitamin D in the treatment of elevations in PTH after controlling hyperphosphatemia in CKD patients.

    <p>Vitamin D is used primarily to treat elevations in PTH after controlling hyperphosphatemia in CKD patients. Vitamin D deficiency worsens bone disease, impairs immunity, and increases the risk of cardiovascular disease. The two primary forms of vitamin D are vitamin D3, synthesized in the skin after exposure to ultraviolet light, and vitamin D2, produced from plant sterols. Supplementation with oral ergocalciferol or cholecalciferol may be necessary, especially in patients with early CKD.</p> Signup and view all the answers

    What is the active form of vitamin D3 analog used in the treatment of CKD?

    <p>The active form of vitamin D3 analog used in the treatment of CKD is Calcitriol (Rocaltrol).</p> Signup and view all the answers

    What is the role of cinacalcet (Sensipar) in inhibiting PTH release in CKD patients?

    <p>Cinacalcet (Sensipar) is a 'calcimimetic' which mimics the actions of calcium on the parathyroid gland and causes a further reduction in PTH by increasing the sensitivity of the calcium receptor on the parathyroid gland.</p> Signup and view all the answers

    What are the alternatives to calcitriol for treating CKD patients with secondary hyperparathyroidism, and how do they differ in their effects?

    <p>Newer vitamin D analogs, such as paricalcitol and doxercalciferol, are alternatives to calcitriol that cause less hypercalcemia.</p> Signup and view all the answers

    Which medications are used to stabilize myocardial cells to prevent arrhythmias in severe hyperkalemia?

    <p>Calcium gluconate</p> Signup and view all the answers

    List three medications used to shift potassium intracellularly for the management of hyperkalemia.

    <p>Insulin, dextrose, sodium bicarbonate</p> Signup and view all the answers

    Name two medications that stimulate potassium elimination in the context of hyperkalemia management.

    <p>Albuterol, furosemide</p> Signup and view all the answers

    What are the three drugs used to bind potassium in the GI tract for hyperkalemia treatment, and what are their specific dosing, warnings, and monitoring requirements?

    <p>Sodium polystyrene sulfonate, patiromer, sodium zirconium cyclosilicate; Each has specific dosing, warnings, side effects, and monitoring requirements.</p> Signup and view all the answers

    Name two treatment options for metabolic acidosis in renal disease and describe their associated monitoring and precautions.

    <p>Sodium bicarbonate, sodium citrate/citric acid solutions; Associated with monitoring and precautions.</p> Signup and view all the answers

    What are the two primary types of dialysis in stage 5 renal disease, and how do they function?

    <p>Hemodialysis (HD) and peritoneal dialysis (PD); HD involves pumping the patient's blood through a semipermeable dialysis filter, while in PD, a dialysis solution is left in the abdomen to 'dwell' for a period of time, then drained.</p> Signup and view all the answers

    What should be considered when using drugs for managing hyperkalemia and metabolic acidosis in the context of patient comorbidities and other medications?

    <p>Specific mechanisms, dosing, monitoring requirements, and caution in the context of patient comorbidities and other medications should be considered.</p> Signup and view all the answers

    What becomes necessary in stage 5 renal disease and what are the specific dosing, warnings, and monitoring requirements for the drugs used in its treatment?

    <p>Dialysis becomes necessary; Drugs for treatment of hyperkalemia include sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate, each with specific dosing, warnings, side effects, and monitoring requirements.</p> Signup and view all the answers

    What is the role of pharmacists in assessing kidney impairment and ensuring safe medication dosing for CKD patients?

    <p>They play a role in assessing kidney impairment and ensuring safe medication dosing for CKD patients.</p> Signup and view all the answers

    What are the potential side effects of calcium-based binders and why is careful administration timing crucial for phosphate binders?

    <p>Potential side effects of calcium-based binders; Careful administration timing is crucial for avoiding interactions with levothyroxine and antibiotic medications.</p> Signup and view all the answers

    When should serum creatinine and potassium be monitored after initiating ACE inhibitors or ARBs in patients with kidney disease?

    <p>Serum creatinine and potassium should be monitored after initiating ACE inhibitors or ARBs in patients with kidney disease.</p> Signup and view all the answers

    What are the potential consequences of CKD on calcium, phosphate, and vitamin D balance, and how can patients with albuminuria be managed to prevent kidney disease progression?

    <p>CKD disrupts Ca, P04, and vitamin D balance, leading to increased PTH, bone demineralization, and anemia; Recommended in all patients with albuminuria to prevent kidney disease progression.</p> Signup and view all the answers

    Explain the factors affecting drug removal during dialysis and how they influence the removal of medications from the body.

    <p>Factors affecting drug removal during dialysis include molecular weight/size, volume of distribution, protein-binding, membrane characteristics, and blood flow rate. Smaller molecules are more readily removed by dialysis, drugs with a large volume of distribution are less likely to be removed, highly protein-bound drugs are less likely to be removed, high-flux and high-efficiency membranes remove more substances, and higher dialysis blood flow rates increase drug removal over a given time interval.</p> Signup and view all the answers

    Describe the process of peritoneal dialysis (PD) and how it differs from hemodialysis (HD).

    <p>In peritoneal dialysis, a dialysis solution containing glucose is pumped into the peritoneal cavity, and the peritoneal membrane acts as the semipermeable membrane. The solution is left in the abdomen to 'dwell' for a period of time, then is drained, and this cycle is repeated throughout the day, every day. PD is performed by the patient at home. In contrast, hemodialysis involves the use of a dialyzer to remove waste and extra fluids from the blood. HD is typically a 3 - 4 hour process, several times per week, and can be done at home more frequently.</p> Signup and view all the answers

    Explain the role of the peritoneal membrane in peritoneal dialysis (PD) and how it functions as the semipermeable membrane.

    <p>In peritoneal dialysis, the peritoneal membrane acts as the semipermeable membrane through which the exchange of waste products and extra fluids occurs. The dialysis solution is pumped into the peritoneal cavity and is left to 'dwell' for a period of time, allowing the peritoneal membrane to facilitate the removal of waste and extra fluids from the body.</p> Signup and view all the answers

    Discuss the differences between home hemodialysis (HD) and peritoneal dialysis (PD) in terms of frequency and process.

    <p>Patients who do home hemodialysis can do it more frequently (e.g., 5-6 times per week) compared to the typical 3-4 times per week for in-center hemodialysis. In peritoneal dialysis, the process involves pumping a dialysis solution into the peritoneal cavity, allowing it to 'dwell' for a period of time, and then draining it, which is repeated throughout the day, every day.</p> Signup and view all the answers

    Explain the significance of drug removal during dialysis for the correct dosing and interval of medications, and provide examples of medications that are removed during dialysis.

    <p>The amount of medication cleared during dialysis is crucial for recommending the correct dose and interval of medications. Medications that are removed during dialysis, including many antibiotics, must be given after dialysis or may require a supplemental dose following dialysis to achieve the desired therapeutic effect.</p> Signup and view all the answers

    Describe the dialysis factors that influence drug removal during dialysis, and explain how they impact the removal of medications from the body.

    <p>Dialysis factors such as membrane characteristics (high-flux and high-efficiency), blood flow rate, and the type of dialysis filter used can significantly influence drug removal during dialysis. High-flux and high-efficiency membranes remove more substances, and higher dialysis blood flow rates increase drug removal over a given time interval.</p> Signup and view all the answers

    Explain the process of home hemodialysis and the potential frequency of treatment compared to in-center hemodialysis.

    <p>Patients who do home hemodialysis can perform it more frequently, typically 5-6 times per week, compared to in-center hemodialysis, which is usually done 3-4 times per week for a 3-4 hour process.</p> Signup and view all the answers

    Discuss the role of the pharmacist in considering drug removal during dialysis when recommending medication dosing for patients undergoing dialysis.

    <p>Pharmacists must consider the amount of medication cleared during dialysis to recommend the correct dose and interval of medications for patients undergoing dialysis, especially for medications that are removed during dialysis and may require adjustments in dosing timing or supplemental doses to ensure therapeutic efficacy.</p> Signup and view all the answers

    1. What are the treatment options for secondary hyperparathyroidism in CKD, and how do they help regulate calcium, phosphorus, and PTH levels?

    <p>Treatment options include vitamin D analogs (e.g., calcitriol, calcifediol, paricalcitol) and calcimimetic agents (e.g., cinacalcet, etelcalcetide) which help regulate calcium, phosphorus, and PTH levels.</p> Signup and view all the answers

    1. What are the treatment options for anemia of chronic kidney disease (CKD), and what risks are associated with these treatments?

    <p>Treatment options include erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa. Risks associated with these treatments include elevated blood pressure and thrombosis.</p> Signup and view all the answers

    1. Under what conditions should ESAs be used cautiously and discontinued in CKD patients, and why?

    <p>ESAs should be used cautiously when hemoglobin is less than 10 g/dL and discontinued if it exceeds 11 g/dL due to increased risk of thromboembolic disease.</p> Signup and view all the answers

    1. Why is adequate iron availability crucial for the effectiveness of ESAs in CKD patients, and what supplementation may be necessary in ESRD patients?

    <p>Adequate iron availability is crucial for the effectiveness of ESAs. Intravenous iron supplementation may be necessary in ESRD patients due to reduced GI absorption and blood loss from dialysis.</p> Signup and view all the answers

    1. What are the primary causes of hyperkalemia in CKD patients, and what are the symptoms and potential severe outcomes associated with hyperkalemia?

    <p>Primary causes include decreased renal excretion due to kidney failure, high dietary potassium intake, or drugs that interfere with potassium excretion. Symptoms can include muscle weakness, bradycardia, and fatal arrhythmias. The risk for severe outcomes increases with higher potassium levels.</p> Signup and view all the answers

    1. How is hyperkalemia managed, and what are the treatment options for severe cases?

    <p>Management involves monitoring ECG, dietary restriction of potassium, discontinuation of potassium-sparing medications, use of potassium-lowering agents, or in severe cases, dialysis.</p> Signup and view all the answers

    1. Why might CKD patients with elevated potassium levels require ECG monitoring, and at what potassium level is hyperkalemia concerning?

    <p>Patients with elevated potassium levels may require ECG monitoring to assess the risk of severe outcomes. Hyperkalemia is concerning at any level above 5 mEq/L.</p> Signup and view all the answers

    1. What factors influence renal potassium excretion, and what role does insulin play in potassium regulation?

    <p>Renal potassium excretion is influenced by factors such as aldosterone, diuretics, urine flow, and negatively charged ions in the distal tubule. Insulin helps shift potassium into cells, offsetting acute rises in potassium from meals.</p> Signup and view all the answers

    1. What is the primary cause of anemia in CKD, and what symptoms are associated with it?

    <p>Anemia in CKD is primarily due to reduced erythropoietin (EPO) production by the kidneys, leading to decreased hemoglobin levels and symptoms such as fatigue and pale skin.</p> Signup and view all the answers

    1. What is the role of ESAs in managing anemia in CKD, and why may IV iron supplementation be necessary in ESRD patients?

    <p>ESAs stimulate RBC production, which requires adequate iron availability. IV iron supplementation may be necessary in ESRD patients due to reduced GI absorption and blood loss from dialysis.</p> Signup and view all the answers

    1. What are the treatment options for secondary hyperparathyroidism in CKD, and how do they help regulate calcium, phosphorus, and PTH levels?

    <p>Treatment options include vitamin D analogs (e.g., calcitriol, calcifediol, paricalcitol) and calcimimetic agents (e.g., cinacalcet, etelcalcetide) which help regulate calcium, phosphorus, and PTH levels.</p> Signup and view all the answers

    1. What is the normal potassium level, and at what level is hyperkalemia concerning in CKD patients?

    <p>The normal potassium level is 3.5 - 5 mEq/L. Hyperkalemia is concerning at any level above 5 mEq/L.</p> Signup and view all the answers

    Name three treatment options for secondary hyperparathyroidism in chronic kidney disease (CKD).

    <p>Vitamin D analogs (calcitriol, calcifediol, doxercalciferol, paricalcitol), calcimimetic agents (cinacalcet, etelcalcetide)</p> Signup and view all the answers

    What are the treatment options for anemia of chronic kidney disease (CKD)?

    <p>Erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa</p> Signup and view all the answers

    At what hemoglobin level should ESAs be used cautiously, and when should they be discontinued in CKD patients?

    <p>Cautiously when hemoglobin is less than 10 g/dL, discontinued if it exceeds 11 g/dL</p> Signup and view all the answers

    Why is adequate iron availability crucial for the effectiveness of ESAs in CKD patients?

    <p>Adequate iron availability is crucial for the effectiveness of ESAs because it is necessary for RBC production</p> Signup and view all the answers

    What are the primary causes of hyperkalemia in CKD patients?

    <p>Decreased renal excretion due to kidney failure, high dietary potassium intake, drugs that interfere with potassium excretion</p> Signup and view all the answers

    What are the symptoms of hyperkalemia?

    <p>Muscle weakness, bradycardia, fatal arrhythmias</p> Signup and view all the answers

    What is the normal potassium level and at what level is hyperkalemia concerning?

    <p>Normal potassium level is 3.5 - 5 mEq/L, hyperkalemia is concerning at any level above 5 mEq/L</p> Signup and view all the answers

    What factors influence renal potassium excretion?

    <p>Aldosterone, diuretics, urine flow, negatively charged ions in the distal tubule</p> Signup and view all the answers

    What is the primary cause of anemia in CKD patients?

    <p>Reduced erythropoietin (EPO) production by the kidneys</p> Signup and view all the answers

    What is the role of insulin in regulating potassium levels in the body?

    <p>Insulin helps shift potassium into cells, offsetting acute rises in potassium from meals</p> Signup and view all the answers

    Why may IV iron supplementation be necessary in end-stage renal disease (ESRD) patients?

    <p>Due to reduced GI absorption and blood loss from dialysis</p> Signup and view all the answers

    What are the potential management options for hyperkalemia?

    <p>Dietary restriction of potassium, discontinuation of potassium-sparing medications, use of potassium-lowering agents, dialysis in severe cases</p> Signup and view all the answers

    Study Notes

    Kidney Disease Management and Medication Dosing

    • Common medications and substances that can cause renal disease include aminoglycosides, NSAIDs, amphotericin B, polymyxins, cisplatin, radiographic contrast dye, cyclosporine, and loop diuretics.
    • Creatinine clearance (CrCl) is calculated using the Cockcroft-Gault equation, which takes into account patient age, serum creatinine (SCr), and weight.
    • Blood urea nitrogen (BUN) and SCr are used to estimate kidney function, with BUN measuring urea levels and SCr indicating muscle metabolism. Normal SCr range is 0.6-1.3 mg/dL.
    • The Cockcroft-Gault equation for CrCl is commonly used for medication dosing, but its accuracy may be affected by low muscle mass, obesity, liver disease, pregnancy, or high muscle mass.
    • Pharmacists typically base medication dosing recommendations on CrCl, while a few specific drugs use glomerular filtration rate (GFR) for dosing adjustments, such as SGLT2 inhibitors and metformin.
    • CKD-EPI and MDRD equations are used for staging kidney disease and dosing select drugs like metformin and SGLT2 inhibitors.
    • Estimated GFR (eGFR) is calculated using the MDRD and CKD-EPI equations, with albuminuria being a key indicator of kidney disease severity.
    • GFR and degree of albuminuria are used to assess the severity of kidney disease, with a GFR < 60 mL/min/1.73 m2 and/or albuminuria indicating chronic kidney disease (CKD) and the need for specific treatments.
    • Hypertension causes and worsens CKD, with a target systolic blood pressure (SBP) < 120 mmHg recommended for patients with hypertension and CKD.
    • An ACE inhibitor or ARB is first-line for patients with CKD, hypertension, and albuminuria, as renin-angiotensin-aldosterone system (RAAS) inhibition reduces CKD progression.
    • When starting treatment with an ACE inhibitor or ARB, the baseline SCr can increase by up to 30%, which is expected and should not prompt treatment cessation.
    • The 2021 KDIGO Guideline on Blood Pressure in CKD recommends a lower target SBP for those with hypertension and CKD, compared to the general population.

    Phosphate Binders in Chronic Kidney Disease

    • Initial CKD treatment involves dietary phosphate restriction and may progress to requiring phosphate binders
    • Phosphate binders block P04 absorption in the intestine and should be taken with meals
    • Three types of phosphate binders: aluminum-based, calcium-based, and aluminum-free, calcium-free drugs
    • CKD disrupts Ca, P04, and vitamin D balance, leading to increased PTH, bone demineralization, and anemia
    • Aluminum-based binders are potent but rarely used due to aluminum accumulation risk
    • Calcium-based binders, first-line treatment, can cause hypercalcemia and constipation
    • Aluminum-free, calcium-free binders are less likely to cause hypercalcemia but are more expensive
    • Lanthanum carbonate and sevelamer are non-calcium, non-aluminum binders with specific considerations and side effects
    • Phosphate binders have various drug interactions and should be administered with caution alongside other medications
    • Sucroferric oxyhydroxide and ferric citrate are iron-based binders and have specific interaction considerations
    • Lanthanum carbonate has interactions with aluminum-, calcium-, or magnesium-containing antacids and quinolone antibiotics
    • Careful administration timing is crucial for avoiding interactions with levothyroxine and antibiotic medications

    Phosphate Binders in Chronic Kidney Disease

    • Initial CKD treatment involves dietary phosphate restriction and may progress to requiring phosphate binders
    • Phosphate binders block P04 absorption in the intestine and should be taken with meals
    • Three types of phosphate binders: aluminum-based, calcium-based, and aluminum-free, calcium-free drugs
    • CKD disrupts Ca, P04, and vitamin D balance, leading to increased PTH, bone demineralization, and anemia
    • Aluminum-based binders are potent but rarely used due to aluminum accumulation risk
    • Calcium-based binders, first-line treatment, can cause hypercalcemia and constipation
    • Aluminum-free, calcium-free binders are less likely to cause hypercalcemia but are more expensive
    • Lanthanum carbonate and sevelamer are non-calcium, non-aluminum binders with specific considerations and side effects
    • Phosphate binders have various drug interactions and should be administered with caution alongside other medications
    • Sucroferric oxyhydroxide and ferric citrate are iron-based binders and have specific interaction considerations
    • Lanthanum carbonate has interactions with aluminum-, calcium-, or magnesium-containing antacids and quinolone antibiotics
    • Careful administration timing is crucial for avoiding interactions with levothyroxine and antibiotic medications

    Managing Hyperkalemia and Metabolic Acidosis in Renal Disease

    • Drugs that raise potassium levels include ACE inhibitors, heparin, aldosterone receptor antagonists, NSAIDs, and potassium-containing IV fluids.
    • In severe hyperkalemia, the urgent clinical need is to stabilize myocardial cells and rapidly shift potassium intracellularly or induce elimination from the body.
    • Medication options for hyperkalemia management include calcium gluconate, regular insulin, dextrose, sodium bicarbonate, albuterol, furosemide, sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate.
    • Calcium gluconate stabilizes myocardial cells to prevent arrhythmias but does not decrease potassium levels.
    • Insulin, dextrose, and sodium bicarbonate are used to shift potassium intracellularly.
    • Albuterol and furosemide stimulate potassium elimination.
    • Sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate bind potassium in the GI tract, with varying onset times and routes of administration.
    • Drugs for treatment of hyperkalemia include sodium polystyrene sulfonate, patiromer, and sodium zirconium cyclosilicate, each with specific dosing, warnings, side effects, and monitoring requirements.
    • Metabolic acidosis in renal disease can be treated with sodium bicarbonate or sodium citrate/citric acid solutions, with associated monitoring and precautions.
    • Dialysis becomes necessary in stage 5 renal disease, with the two primary types being hemodialysis (HD) and peritoneal dialysis (PD).
    • In hemodialysis, the patient's blood is pumped to a dialysis machine and runs through a semipermeable dialysis filter to remove waste products, electrolytes, and excess fluid.
    • Drugs used for managing hyperkalemia and metabolic acidosis in renal disease have specific mechanisms, dosing, and monitoring requirements, and should be used with caution in the context of patient comorbidities and other medications.

    Management of Secondary Hyperparathyroidism, Anemia, and Hyperkalemia in CKD

    • Secondary hyperparathyroidism is treated with vitamin D analogs such as calcitriol, calcifediol, doxercalciferol, paricalcitol, and calcimimetic agents like cinacalcet and etelcalcetide, which help regulate calcium, phosphorus, and PTH levels.
    • Treatment options for anemia of chronic kidney disease (CKD) include erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa, which can prevent the need for blood transfusions, but have risks like elevated blood pressure and thrombosis.
    • ESAs should be used cautiously when hemoglobin is less than 10 g/dL and discontinued if it exceeds 11 g/dL due to increased risk of thromboembolic disease.
    • Adequate iron availability is crucial for the effectiveness of ESAs, and intravenous iron supplementation is often necessary in CKD patients, particularly in end-stage renal disease (ESRD) due to reduced GI absorption and blood loss from dialysis.
    • Hyperkalemia, defined as potassium level > 5 mEq/L, is primarily caused by decreased renal excretion due to kidney failure, high dietary potassium intake, or drugs that interfere with potassium excretion, and is more prevalent in hospitalized patients and those with diabetes.
    • Symptoms of hyperkalemia can include muscle weakness, bradycardia, and fatal arrhythmias, and the risk for severe outcomes increases with higher potassium levels.
    • Management of hyperkalemia involves monitoring ECG, and treatment may include dietary restriction of potassium, discontinuation of potassium-sparing medications, use of potassium-lowering agents, or in severe cases, dialysis.
    • Hyperkalemia can be asymptomatic, and patients with elevated potassium levels may require ECG monitoring to assess the risk of severe outcomes.
    • The normal potassium level is 3.5 - 5 mEq/L, and hyperkalemia is concerning at any level above 5 mEq/L, with the most common cause being decreased renal excretion due to kidney failure.
    • Renal potassium excretion is influenced by factors such as aldosterone, diuretics, urine flow, and negatively charged ions in the distal tubule, while insulin helps shift potassium into cells, offsetting acute rises in potassium from meals.
    • Anemia in CKD is primarily due to reduced erythropoietin (EPO) production by the kidneys, leading to decreased hemoglobin levels and symptoms such as fatigue and pale skin, exacerbated by the inflammatory state of CKD.
    • Anemia management involves ESAs to stimulate RBC production, which requires adequate iron availability, and IV iron supplementation may be necessary in ESRD patients due to reduced GI absorption and blood loss from dialysis

    Management of Secondary Hyperparathyroidism, Anemia, and Hyperkalemia in CKD

    • Secondary hyperparathyroidism is treated with vitamin D analogs such as calcitriol, calcifediol, doxercalciferol, paricalcitol, and calcimimetic agents like cinacalcet and etelcalcetide, which help regulate calcium, phosphorus, and PTH levels.
    • Treatment options for anemia of chronic kidney disease (CKD) include erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa, which can prevent the need for blood transfusions, but have risks like elevated blood pressure and thrombosis.
    • ESAs should be used cautiously when hemoglobin is less than 10 g/dL and discontinued if it exceeds 11 g/dL due to increased risk of thromboembolic disease.
    • Adequate iron availability is crucial for the effectiveness of ESAs, and intravenous iron supplementation is often necessary in CKD patients, particularly in end-stage renal disease (ESRD) due to reduced GI absorption and blood loss from dialysis.
    • Hyperkalemia, defined as potassium level > 5 mEq/L, is primarily caused by decreased renal excretion due to kidney failure, high dietary potassium intake, or drugs that interfere with potassium excretion, and is more prevalent in hospitalized patients and those with diabetes.
    • Symptoms of hyperkalemia can include muscle weakness, bradycardia, and fatal arrhythmias, and the risk for severe outcomes increases with higher potassium levels.
    • Management of hyperkalemia involves monitoring ECG, and treatment may include dietary restriction of potassium, discontinuation of potassium-sparing medications, use of potassium-lowering agents, or in severe cases, dialysis.
    • Hyperkalemia can be asymptomatic, and patients with elevated potassium levels may require ECG monitoring to assess the risk of severe outcomes.
    • The normal potassium level is 3.5 - 5 mEq/L, and hyperkalemia is concerning at any level above 5 mEq/L, with the most common cause being decreased renal excretion due to kidney failure.
    • Renal potassium excretion is influenced by factors such as aldosterone, diuretics, urine flow, and negatively charged ions in the distal tubule, while insulin helps shift potassium into cells, offsetting acute rises in potassium from meals.
    • Anemia in CKD is primarily due to reduced erythropoietin (EPO) production by the kidneys, leading to decreased hemoglobin levels and symptoms such as fatigue and pale skin, exacerbated by the inflammatory state of CKD.
    • Anemia management involves ESAs to stimulate RBC production, which requires adequate iron availability, and IV iron supplementation may be necessary in ESRD patients due to reduced GI absorption and blood loss from dialysis

    Management of Secondary Hyperparathyroidism, Anemia, and Hyperkalemia in CKD

    • Secondary hyperparathyroidism is treated with vitamin D analogs such as calcitriol, calcifediol, doxercalciferol, paricalcitol, and calcimimetic agents like cinacalcet and etelcalcetide, which help regulate calcium, phosphorus, and PTH levels.
    • Treatment options for anemia of chronic kidney disease (CKD) include erythropoiesis-stimulating agents (ESAs) like epoetin alfa and darbepoetin alfa, which can prevent the need for blood transfusions, but have risks like elevated blood pressure and thrombosis.
    • ESAs should be used cautiously when hemoglobin is less than 10 g/dL and discontinued if it exceeds 11 g/dL due to increased risk of thromboembolic disease.
    • Adequate iron availability is crucial for the effectiveness of ESAs, and intravenous iron supplementation is often necessary in CKD patients, particularly in end-stage renal disease (ESRD) due to reduced GI absorption and blood loss from dialysis.
    • Hyperkalemia, defined as potassium level > 5 mEq/L, is primarily caused by decreased renal excretion due to kidney failure, high dietary potassium intake, or drugs that interfere with potassium excretion, and is more prevalent in hospitalized patients and those with diabetes.
    • Symptoms of hyperkalemia can include muscle weakness, bradycardia, and fatal arrhythmias, and the risk for severe outcomes increases with higher potassium levels.
    • Management of hyperkalemia involves monitoring ECG, and treatment may include dietary restriction of potassium, discontinuation of potassium-sparing medications, use of potassium-lowering agents, or in severe cases, dialysis.
    • Hyperkalemia can be asymptomatic, and patients with elevated potassium levels may require ECG monitoring to assess the risk of severe outcomes.
    • The normal potassium level is 3.5 - 5 mEq/L, and hyperkalemia is concerning at any level above 5 mEq/L, with the most common cause being decreased renal excretion due to kidney failure.
    • Renal potassium excretion is influenced by factors such as aldosterone, diuretics, urine flow, and negatively charged ions in the distal tubule, while insulin helps shift potassium into cells, offsetting acute rises in potassium from meals.
    • Anemia in CKD is primarily due to reduced erythropoietin (EPO) production by the kidneys, leading to decreased hemoglobin levels and symptoms such as fatigue and pale skin, exacerbated by the inflammatory state of CKD.
    • Anemia management involves ESAs to stimulate RBC production, which requires adequate iron availability, and IV iron supplementation may be necessary in ESRD patients due to reduced GI absorption and blood loss from dialysis

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Renal & Liver Disease PDF
    Renal RxPrep Book 2022 PDF

    Description

    Test your knowledge of kidney disease management and medication dosing with this quiz. Explore common medications that can cause renal disease, calculation of creatinine clearance, assessment of kidney function, and recommended medications for patients with chronic kidney disease (CKD) and hypertension.

    More Like This

    Renal Disease Classification Quiz
    15 questions

    Renal Disease Classification Quiz

    MotivatedSugilite avatar
    MotivatedSugilite
    Dental Management for Renal Patients
    25 questions

    Dental Management for Renal Patients

    StrikingHurdyGurdy avatar
    StrikingHurdyGurdy
    Renal Disease
    10 questions

    Renal Disease

    UserFriendlySagacity4401 avatar
    UserFriendlySagacity4401
    Renal Disease pt 2
    10 questions

    Renal Disease pt 2

    UserFriendlySagacity4401 avatar
    UserFriendlySagacity4401
    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser